Search results for "Vaccines"
MKSAP Quiz: Evaluation for influenza immunization
A 49-year-old man is evaluated for influenza immunization. Two weeks ago, he underwent surgical resection for stage III colon cancer. He will begin a 3-month course of adjuvant chemotherapy in 3 weeks. What is the preferred influenza immunization strategy?
https://immattersacp.org/weekly/archives/2022/05/24/3.htm
24 May 2022
Shingles vaccine can be given before starting tofacitinib, industry-funded study says
The authors concluded that tofacitinib alone for the treatment of rheumatoid arthritis should be considered to help reduce the risk of shingles in vaccinated patients, provided that patients' arthritis remains controlled on the drug.
https://immattersacp.org/weekly/archives/2017/08/29/5.htm
29 Aug 2017
August is National Immunization Awareness Month
ACP urges adults to get vaccinations to protect against preventable diseases.
https://immattersacp.org/weekly/archives/2023/08/15/5.htm
15 Aug 2023
ACIP recommends hepatitis B vaccine for diabetics, HPV vaccine for men
Two new recommendations from the Advisory Committee on Immunization Practices (ACIP) outline hepatitis B vaccination for diabetic adults and human papillomavirus vaccination in males ages 9 to 26.
https://immattersacp.org/weekly/archives/2012/01/10/2.htm
10 Jan 2012
ACIP revises recommendations on pneumococcal vaccine intervals for older adults
The Advisory Committee on Immunization Practices (ACIP) had previously recommended an interval of 6 to 12 months for the PCV13-PPSV23 sequence in immunocompetent adults 65 years or age and older. After review of the evidence, a new interval is now recommended.
https://immattersacp.org/weekly/archives/2015/09/15/5.htm
15 Sep 2015
ACIP adds new vaccine to HPV recommendations
The Advisory Committee on Immunization Practices (ACIP) recommended the 9-valent human papillomavirus (HPV) vaccine (Gardasil 9) in last week's Morbidity and Mortality Weekly Report (MMWR).
https://immattersacp.org/weekly/archives/2015/03/31/4.htm
31 Mar 2015
Studies look at effectiveness of bivalent booster, fluvoxamine plus inhaled budesonide for COVID-19
After four weeks, bivalent booster vaccines were 47.5% effective against hospitalization or death from COVID-19, a study in North Carolina found, while a Brazilian trial showed that fluvoxamine plus inhaled budesonide significantly reduced the risk of progression to severe disease among high-risk patients with symptomatic COVID-19.
https://immattersacp.org/weekly/archives/2023/04/18/2.htm
18 Apr 2023
Recommendations on avoiding drug-drug interactions, data on recovery after ventilation
A panel of experts offered advice on avoiding drug-drug interactions when prescribing nirmatrelvir-ritonavir for patients with COVID-19, and two studies offered good news about postdischarge outcomes in COVID-19 patients who underwent a tracheostomy.
https://immattersacp.org/weekly/archives/2022/03/01/4.htm
1 Mar 2022
Recommendations issued on pneumococcal vaccine in elderly patients
The Advisory Committee on Immunization Practices (ACIP) recommends that the 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) should be routinely administered in series to all adults who are at least 65 years of age, the CDC announced last week.
https://immattersacp.org/weekly/archives/2014/09/23/4.htm
23 Sep 2014
New COVID-19 boosters authorized and recommended
The CDC has recommended the new formulations of the mRNA vaccines, targeted at the BA.4 and BA.5 lineages of the omicron variant, for adults and adolescents who last received a COVID-19 shot at least two months ago.
https://immattersacp.org/weekly/archives/2022/09/06/2.htm
6 Sep 2022